Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Short-term Investments (2023 - 2025)

Mangoceuticals' Short-term Investments history spans 3 years, with the latest figure at $16942.0 for Q3 2025.

  • For Q3 2025, Short-term Investments changed 0.0% year-over-year to $16942.0; the TTM value through Sep 2025 reached $16942.0, changed 0.0%, while the annual FY2024 figure was $16942.0, 0.0% changed from the prior year.
  • Short-term Investments for Q3 2025 was $16942.0 at Mangoceuticals, roughly flat from $16942.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $16942.0 in Q4 2023 and bottomed at $16942.0 in Q4 2023.
  • The 3-year median for Short-term Investments is $16942.0 (2023), against an average of $16942.0.
  • The largest YoY upside for Short-term Investments was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Short-term Investments shows it stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then changed by 0.0% to $16942.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Short-term Investments are $16942.0 (Q3 2025), $16942.0 (Q2 2025), and $16942.0 (Q1 2025).